Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas

Journal of Dairy Science

Volumn 92, Issue 11, 2009, Pages 5378-5385

  Schack, L ^a,b   Lange, A ^c   Kelsen, J ^d   Agnholt, J ^d   Christensen, B ^a   Petersen, T E ^a   Sorensen E S ^a,b  

^a Protein Chemistry Laboratory   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Department of Pediatrics ^*  (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bovine milk; Human milk; Infant formula; Osteopontin

Indexed keywords

BOVINAE;

EID: 70350315761     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2009-2360     Document Type: Article

References (41)

1. Agnholt, J., and K. Kaltoft. 2001. In situ activated intestinal T cells expanded in vitro-without addition of antigen-produce IFN- gamma and IL-10 and preserve their function during growth. Exp. Clin. Immunogenet. 18:213-225.
2. Agnholt, J., J. Kelsen, L. Schack, C. L. Hvas, J. F. Dahlerup, and E. S. Sørensen. 2007. Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand. J. Immunol. 65:453-460.
3. Ashkar, S., G. F. Weber, V. Panoutsakopoulou, M. E. Sanchirico, M. Jansson, S. Zawaideh, S. R. Rittling, D. T. Denhardt, M. J. Glimcher, and H. Cantor. 2000. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity. Science 287:860-864.
4. Asplin, J. R., D. Arsenault, J. H. Parks, F. L. Coe, and J. R. Hoyer. 1998. Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 53:194-199.
5. Azuma, N., A. Maeta, K. Fukuchi, and C. Kanno. 2006. A rapid method for purifying osteopontin from bovine milk and interaction between osteopontin and other milk proteins. Int. Dairy J. 16:370-378.
6. Chatterton, D. E. W., J. T. Rasmussen, C. W. Heegaard, E. S. Sørensen, and T. E. Petersen. 2004. In vitro digestion of novel milk protein ingredients for use in infant formulas: Research on biological functions. Trends Food Sci. Technol. 15:373-383.
7. Christensen, B., M. S. Nielsen, K. F. Haselmann, T. E. Petersen, and E. S. Sørensen. 2005. Posttranslationally modified residues of native human osteopontin are located in clusters. Identification of thirty-six phosphorylation and five O-glycosylation sites and their biological implications. Biochem. J. 390:285-292.
8. Cunningham, A. S., D. B. Jelliffe, and E. F. Jelliffe. 1991. Breast-feeding and health in the 1980s: A global epidemiologic review. J. Pediatr. 118:659-666.
9. Dewey, K. G., M. J. Heinig, and L. A. Nommsen-Rivers. 1995. Differences in morbidity between breast-fed and formula-fed infants. J. Pediatr. 126:696-702.
10. Field, C. J. 2005. The immunological components of human milk and their effect on immune development in infants. J. Nutr. 135:1-4.
11. Gericke, A., C. Qin, L. Spevak, Y. Fujimoto, W. T. Butler, E. S. Sørensen, and A. L. Boskey. 2005. Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif. Tissue Int. 77:45-54.
12. Hambreus, L., E. Forsum, and B. Lönnerdal. 1977. Nutritional aspects of breast milk versus cow's milk formula. Pages 116-124 in Food and Immunology, Symposia of the Swedish Nutrition Foundation. Vol. XIII. L. Hambreus, L.-Å. Hanson, and H. McFarlane, ed. Almqvist and Wiksell, Uppsala, Sweden.
13. Hanson, L. A., M. Korotkova, and E. Telemo. 2003. Breast-feeding, infant formulas, and the immune system. Ann. Allergy Asthma Immunol. 90:59-63.
14. Huffman, S. L., and C. Combest. 1990. Role of breast-feeding in the prevention and treatment of diarrhoea. J. Diarrhoeal Dis. Res. 8:68-81.
15. Kelsen, J., J. Agnholt, H. J. Hoffmann, J. L. Romer, C. L. Hvas, and J. F. Dahlerup. 2005. FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease. Clin. Exp. Immunol. 141:549-557.
16. Lawrence, R. M., and C. A. Pane. 2007. Human breast milk: Current concepts of immunology and infectious diseases. Curr. Probl. Pediatr. Adolesc. Health Care 37:7-36.
17. Mercier, J. C. 1981. Phosphorylation of caseins, present evidence for an amino acid triplet code posttranslationally recognized by specific kinases. Biochimie 63:1-17.
18. Nagatomo, T., S. Ohga, H. Takada, A. Nomura, S. Hikino, M. Imura, K. Ohshima, and T. Hara. 2004. Microarray analysis of human milk cells: Persistent high expression of osteopontin during the lactation period. Clin. Exp. Immunol. 138:47-53.
19. Nau, G. J., L. Liaw, G. L. Chupp, J. S. Berman, B. L. Hogan, and R. A. Young. 1999. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect. Immun. 67:4223-4230.
20. Nemir, M., D. Bhattacharyya, X. Li, K. Singh, A. B. Mukherjee, and B. B. Mukherjee. 2000. Targeted inhibition of osteopontin expression in the mammary gland causes abnormal morphogenesis and lactation deficiency. J. Biol. Chem. 275:969-976.
21. Ohri, R., E. Tung, R. Rajachar, and C. M. Giachelli. 2005. Mitigation of ectopic calcification in osteopontin-deficient mice by exogenous osteopontin. Calcif. Tissue Int. 76:307-315.
22. Ohshima, S., N. Yamaguchi, K. Nishioka, T. Mima, T. Ishii, M. Umeshita-Sasai, H. Kobayashi, M. Shimizu, Y. Katada, S. Wakitani, N. Murata, S. Nomura, H. Matsuno, R. Katayama, S. Kon, M. Inobe, T. Uede, I. Kawase, and Y. Saeki. 2002. Enhanced local production of osteopontin in rheumatoid joints. J. Rheumatol. 29:2061-2067.
23. Patarca, R., G. J. Freeman, R. P. Singh, F. Y. Wei, T. Durfee, F. Blattner, D. C. Regnier, C. A. Kozak, B. A. Mock, H. C. Morse 3rd, T. R. Jerrells, and H. Cantor. 1989. Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170:145-161.
24. Plumer, A., H. Duan, S. Subramaniam, F. L. Lucas, S. Miesfeldt, A. K. Ng, and L. Liaw. 2008. Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer. BMC Cancer 8:38-48.
25. Rittling, S. R., and K. E. Novick. 1997. Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ. 8:1061-1069.
26. Rodrigues, L. R., J. A. Teixeira, F. L. Schmitt, M. Paulsson, and H. Lindmark-Mansson. 2007. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol. Biomarkers Prev. 16:1087-1097.
27. Rollo, E. E., S. J. Hempson, A. Bansal, E. Tsao, I. Habib, S. R. Rittling, D. T. Denhardt, E. R. Mackow, and R. D. Shaw. 2005. The cytokine osteopontin modulates the severity of rotavirus diarrhea. J. Virol. 79:3509-3516.
28. Santana, M. A., and Y. Rosenstein. 2003. What it takes to become an effector T cell: The process, the cells involved, and the mechanisms. J. Cell. Physiol. 195:392-401.
29. Sato, T., T. Nakai, N. Tamura, S. Okamoto, K. Matsuoka, A. Sakuraba, T. Fukushima, T. Uede, and T. Hibi. 2005. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 54:1254-1262.
30. Schack, L., R. Stapulionis, B. Christensen, E. Kofod-Olsen, U. B. Skov Sørensen, T. Vorup-Jensen, E. S. Sørensen, and P. Höllsberg. 2009. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J. Immunol. 182:6943-6950.
31. Senger, D. R., C. A. Perruzzi, A. Papadopoulos, and D. G. Tenen. 1989. Purification of a human milk protein closely similar to tumor- secreted phosphoproteins and osteopontin. Biochim. Biophys. Acta 996:43-48.
32. Sennels, H. P., S. Jacobsen, T. Jensen, M. S. Hansen, M. Ostergaard, H. J. Nielsen, and S. Sørensen. 2007. Biological variation and reference intervals for circulating osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor kappa B ligand and high-sensitivity C-reactive protein. Scand. J. Clin. Lab. Invest. 67:821-835.
33. Sodek, J., B. Ganss, and M. D. McKee. 2000. Osteopontin. Crit. Rev. Oral Biol. Med. 11:279-303.
34. Sørensen, E. S., P. Højrup, and T. E. Petersen. 1995. Posttranslational modifications of bovine osteopontin: Identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 4:2040-2049.
35. Sørensen, E. S., and T. E. Petersen. 1993a. Phosphorylation, glycosylation and amino acid sequence of component PP3 from the proteose peptone fraction of bovine milk. J. Dairy Res. 60:535-542.
36. Sørensen, E. S., and T. E. Petersen. 1993b. Purification and characterization of three proteins isolated from the proteose peptone fraction of bovine milk. J. Dairy Res. 60:189-197.
37. Sørensen, S., S. J. Justesen, and A. H. Johnsen. 2003. Purification and characterization of osteopontin from human milk. Protein Expr. Purif. 30:238-245.
38. Tomita, M., H. Wakabayashi, K. Yamauchi, S. Teraguchi, and H. Hayasawa. 2002. Bovine lactoferrin and lactoferricin derived from milk: Production and applications. Biochem. Cell Biol. 80:109-112.
39. Vogt, M. H., L. Lopatinskaya, M. Smits, C. H. Polman, and L. Nagelkerken. 2003. Elevated osteopontin levels in active relapsing- remitting multiple sclerosis. Ann. Neurol. 53:819-822.
40. Vordermark, D., H. M. Said, A. Katzer, T. Kuhnt, G. Hansgen, J. Dunst, M. Flentje, and M. Bache. 2006. Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system. BMC Cancer 6:207-212.
41. Wang, K. X., and D. T. Denhardt. 2008. Osteopontin: Role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19:333-345.